Everywhere you turn, the media is blasting about the Kratom ban. The abundance of this slander campaign throughout local news outlets is astounding. If you have friends or acquaintances who are new to Kratom and have heard about Kratom through the media, it’s possible the first impression they got regarding this plant was from these negative sources.
This slander of hateful lies comes quickly on the heels of the FDA’s campaign against Kratom. These media centers are using your friends’ ignorance against them.
It has been well documented that negative emotions are easier to distribute amongst humans because humans are actually wired to think negatively. We have a natural inclination towards biased opinions.
This article will give you some helpful information you can use to reduce Kratom ignorance within your community. These facts will share the helpful benefits about this plant the FDA doesn’t want people concentrating on. Instead of thinking the way they want us to think, we need to think according to science – not allowing bias to hinder our views.
The Kratom Slander Campaign
It seems like the FDA director, Scott Gottlieb, is intent on imposing his inaccurate beliefs. . He states Kratom has been the cause of 64 deaths. This is just one example of the harsh campaign set forth by the FDA against Kratom. This is stage 1, the stage where they bring the American public against the plant.
Remember back in the 1980’s, President Ronald Reagan set forth a campaign against marijuana called D.A.R.E.? I can still hear that slogan singing in my head, Dare to keep kids off drugs, it said. This was the beginning of a slander campaign that the FDA used against marijuana.
In fact, there are 118 pages of documents that shared why the FDA thought marijuana wasn’t medicine.
Fast forward to today, and we see this tweet from Scott Gottlieb:
My statement on today’s FDA approval of the first drug with a compound derived from marijuana for treatment of seizures associated with certain rare, severe forms of epilepsy https://t.co/rgc4GNnzbZ pic.twitter.com/zfXqTjxRDv
— Scott Gottlieb, M.D. (@SGottliebFDA) June 25, 2018
As you can clearly see, the FDA DOES think there is medicinal value to marijuana after all. This makes one think that the FDA always knew about the potential of marijuana’s medicinal value from the get-go.
When you compare the slander campaign against marijuana to the campaign they are forcing against Kratom, there are clear similarities and also indications as to what they really want Kratom for.
In a recent post I wrote on how to stop the Kratom ban, I shared information regarding the filing of a patent on an active alkaloid in Kratom. This is not the only one either, another patent was filed last year for active alkaloids in Kratom. Both of these patent filings invention summary share how mitragynine can “help with opiate withdrawal” (This is a direct quote from the patent and no medical claim from us).
The slander campaign against Kratom is clear. The end game for the FDA and big pharma is clear – they want this active compound in Kratom because of, well, let me just share the proof…
In a recent case study, the NCBI shared a report on a man who was experiencing withdrawal symptoms. This study allowed the man to consume Kratom and then observe his reaction, this was what was said:
The patient currently reports adequate pain control. He described a period of withdrawal considerably less intense but more protracted than that from prescription opioids, and follow-up urine screens for drugs of abuse have remained negative. We report the protracted use of kratom for chronic pain treatment and opioid replacement therapy. One striking finding of this report is the extent to which kratom attenuates potentially severe opioid withdrawal, yet cessation of kratom administration itself appears to be associated with modest abstinence symptoms. Although mitragynine’s agonize mu-opioid receptors, respiratory depression, coma, pulmonary edema and death have not, to our knowledge, been associated with human kratom ingestion.
That is the science talking from real human after trials were completed on this plant called Kratom.
Follow the Science
So, how should you start a conversation when communicating to someone about the safety of Kratom? Jane Babin’s statement below clearly indicates what the American Kratom Association calls on the FDA to do. It is puzzling why a group of doctors and scientists are not doing just this, which could mean an underlying agenda on their end.
However, when you follow the science you always come back with a clear report of what Kratom is.
Jane Babin wrote in this letter, asking the DEA to terminate their scheduling of Kratom simply because of the science that follows this plant.
Babin reminds the DEA about the 8-factor analysis test which is used to schedule a substance, and how an 8-factor analysis test has already been completed on Kratom by Dr. Jack Henningfield.
We urge you to share these scientific facts with your friends, family members, and local news outlets so they can continue the education of people who may be swayed to the negative side of Kratom. While you’re at it, make sure you and the close people connected to you have signed the American Kratom Association’s current petition to the DEA, demanding them to stop the scheduling of Kratom.
If Kratom is in the news, chances are it’s going to be in relation to some form of negative reporting. This is in line with the ever popular adage by President Trump calling most media “Fake News.” Remember the saying, ‘there’s no such thing as bad press’? That’s false. Bad press against Kratom can hinder our own campaign for this plant and create a scare among people who are ignorant to the benefits of Kratom. One of the ways you can ensure Kratom is staying on track is through keeping yourself and the people around you educated on this plant.